Shoulder Innovations COO exercises stock options
Shoulder Innovations, Inc. Chief Operating Officer Matthew Fraser Ahearn exercised stock options to acquire a total of 21,664 shares of common stock on April 20, 2026, at exercise prices of $2.8620 and $2.4804 per share.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Shoulder Innovations, Inc. Chief Operating Officer Matthew Fraser Ahearn exercised stock options to acquire a total of 21,664 shares of common stock on April 20, 2026, at exercise prices of $2.8620 and $2.4804 per share. Following these exercises, he directly holds 286,765 common shares. No open-market sales were reported in this filing.
Insider Trade Summary
21,664 shares exercised/converted
Exercise
4 txns
Insider
Ahearn Matthew Fraser
Role
Chief Operating Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option | 7,421 | $0.00 | $0.00 |
| Exercise | Stock Option | 14,243 | $0.00 | $0.00 |
| Exercise | Common Stock | 7,421 | $2.4804 | $18K |
| Exercise | Common Stock | 14,243 | $2.862 | $41K |
Holdings After Transaction:
Stock Option — 51,595 contracts (Direct);
Common Stock — 286,765 shares (Direct)
Footnotes (3)
- F1. Includes the following shares received without consideration as in-kind distributions: (i) 39,404 shares from Genesis Investment Holdings; (ii) 1,572 shares from cultivate(MD) Capital Accelerator Fund, L.P.; (iii) 4,400 shares from Cultivate MD Capital Fund I, LLC; and (iv) 3,869 shares from Cultivate MD Capital Fund II, LP. In prior reports, the reporting person reported beneficial ownership of 215,856 shares of Shoulder Innovations common stock held directly.
- F2. The stock option vested as to one-fourth of the underlying shares on April 19, 2024, and the remaining shares vest in 36 equal increments on the last day of each calendar month thereafter.
- F3. The stock option vested as to one-fourth of the underlying shares on April 1, 2026, and the remaining shares vest in 12 equal increments on the last day of each fiscal quarter beginning on June 30, 2026.
Key Figures
Options exercised: 21,664 shares
Exercise price 1: $2.8620 per share
Exercise price 2: $2.4804 per share
+4 more
7 metrics
Options exercised
21,664 shares
Total common shares acquired via option exercises on April 20, 2026
Exercise price 1
$2.8620 per share
Stock option converted into 14,243 common shares
Exercise price 2
$2.4804 per share
Stock option converted into 7,421 common shares
Common shares held
286,765 shares
Directly owned common stock after reported transactions
Remaining option grant 1
42,731 options
Stock option position after 14,243-share exercise; expires April 23, 2035
Remaining option grant 2
8,864 options
Stock option position after 7,421-share exercise; expires May 9, 2033
Prior direct ownership
215,856 shares
Previously reported direct beneficial ownership referenced in footnote
Key Terms
Stock Option, in-kind distributions, beneficial ownership, underlying shares, +1 more
5 terms
Stock Option financial
"The stock option vested as to one-fourth of the underlying shares on April 19, 2024"
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
in-kind distributions financial
"Includes the following shares received without consideration as in-kind distributions"
beneficial ownership financial
"the reporting person reported beneficial ownership of 215,856 shares of Shoulder Innovations common stock"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
vest financial
"the remaining shares vest in 36 equal increments on the last day of each calendar month"
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did SI’s COO report on this Form 4?
SI’s Chief Operating Officer, Matthew Fraser Ahearn, reported exercising stock options to acquire 21,664 shares of common stock. These option exercises increased his directly held shares without any reported open-market sales in this filing.
At what prices did the SI COO exercise his stock options?
The COO exercised two tranches of stock options into common stock at exercise prices of $2.8620 and $2.4804 per share. These prices reflect the conversion terms of the derivative securities into Shoulder Innovations common stock.
How do the SI COO’s stock options vest according to the Form 4 footnotes?
One stock option grant vested one-fourth of its shares on April 19, 2024, with the rest vesting monthly. Another vested one-fourth on April 1, 2026, with the remaining shares vesting in 12 equal increments each fiscal quarter starting June 30, 2026.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates